The Scientist November 2018

http://www.mirusbio.com

©2018 All rights reserved Mirus Bio LLC. MISSION is a registered trademark of Sigma-Aldrich Co LLC; Mirus Bio and TransIT are registered trademarks of Mirus Bio LLC.

All trademarks are the property of their respective owners.

Lenti issues to address

• optimi

ze

tr

ansf

ect

ion

re

agen

t

• media

ch

a

nge

• multiple ha

rves

ts

• c

o

n

ce

nt

ra

te

v

iru

s

• avoid lo

w

t

ite

rs

ve

ct

or

s

Harness the Power of Lentivirus

The NEW TransIT® Lentivirus System combines the novel technologies of the Mirus Bio TransIT®-Lenti Transfection Reagent

and the Lentivirus Packaging Mix Powered by MISSION® Genomics. Titers of 10^8 can be achieved with an optimized protocol.

Whether you’re a novice or expert, you can rely on these benefits:

For more information, please visit: http://www.mirusbio.com/TransIT® Lentivirus System.

Ready to test? Request a FREE sample of TransIT®-Lenti Transfection Reagent.

Produce higher functional titers with TransIT®-Lenti

than Lipofectamine® 2000 and 3000

Achieve even higher titers with the TransIT® Lentivirus System

and eliminate the need to concentrate

No media change required, single harvest

More Options for Virus Production

NEW! TransIT-VirusGEN® Transfection Reagent

Ideal for Recombinant Adeno-associated

Virus Production